INmune Bio, Inc. ( INMB) - Stock Earnings
INMB Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -6.5 million USD | — USD |
| 2025Q4 | -5.3 million USD | — USD |
| 2026Q1 | -5.4 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
INMB Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -30.0 million USD | 155000 USD |
| 2024 | -42.1 million USD | 14000 USD |
| 2025 | -45.9 million USD | 50000 USD |
| 2026 Est. | — | — |
INMB
Price: $1.45
52 week price:
Earnings Per Share: -1.63 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 49961
Market Capitalization: 36.2 million